Papers associated with muscle (and kcne1)

Limit to papers also referencing gene:
Show all muscle papers

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

	Functional Characterization of a Spectrum of Novel Romano-Ward Syndrome KCNQ1 Variants., Rinné S., Int J Mol Sci. January 10, 2023; 24 (2):
	Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis., Ho HT., Cell Physiol Biochem. November 18, 2021; 55 (6): 679-703.
	4,4'-Diisothiocyanato-2,2'-Stilbenedisulfonic Acid (DIDS) Modulates the Activity of KCNQ1/KCNE1 Channels by an Interaction with the Central Pore Region., Bollmann E., Cell Physiol Biochem. April 8, 2020; 54 (2): 321-332.
	Polyunsaturated fatty acid analogues differentially affect cardiac NaV, CaV, and KV channels through unique mechanisms., Bohannon BM., Elife. March 24, 2020; 9
	Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling., Lee HC, Lee HC., J Med Biol Eng. October 1, 2017; 37 (5): 780-789.
	Molecular cloning and functional expression of the K + channel K V 7.1 and the regulatory subunit KCNE1 from equine myocardium., Pedersen PJ., Res Vet Sci. August 1, 2017; 113 79-86.
	The residue I257 at S4-S5 linker in KCNQ1 determines KCNQ1/KCNE1 channel sensitivity to 1-alkanols., Xie C., Acta Pharmacol Sin. January 1, 2016; 37 (1): 124-33.
	Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel., Liin SI., Proc Natl Acad Sci U S A. May 5, 2015; 112 (18): 5714-9.
	Ginseng gintonin activates the human cardiac delayed rectifier K+ channel: involvement of Ca2+/calmodulin binding sites., Choi SH., Mol Cells. September 1, 2014; 37 (9): 656-63.
	Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology., Oliveras A., Arterioscler Thromb Vasc Biol. July 1, 2014; 34 (7): 1522-30.
	Domain-domain interactions determine the gating, permeation, pharmacology, and subunit modulation of the IKs ion channel., Zaydman MA., Elife. March 12, 2014; 3 e03606.
	Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks)., Li Y., Proc Natl Acad Sci U S A. November 19, 2013; 110 (47): 18922-7.
	Involvement of the eukaryotic initiation factor 6 and kermit2/gipc2 in Xenopus laevis pronephros formation., Tussellino M., Int J Dev Biol. January 1, 2012; 56 (5): 357-62.
	Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state., Larsen AP., Biophys J. August 17, 2011; 101 (4): 818-27.
	Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase., Alesutan I., Mol Membr Biol. February 1, 2011; 28 (2): 79-89.
	PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors., Matavel A., J Mol Cell Cardiol. May 1, 2009; 46 (5): 704-12.
	Functional implications of KCNE subunit expression for the Kv7.5 (KCNQ5) channel., Roura-Ferrer M., Cell Physiol Biochem. January 1, 2009; 24 (5-6): 325-34.
	Counting membrane-embedded KCNE beta-subunits in functioning K+ channel complexes., Morin TJ., Proc Natl Acad Sci U S A. February 5, 2008; 105 (5): 1478-82.
	Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis., Mancilla-Simbro C., Br J Pharmacol. February 1, 2008; 153 (3): 448-58.
	Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure., Watanabe E., Circ J. April 1, 2007; 71 (4): 471-8.
	KCNE2 is colocalized with KCNQ1 and KCNE1 in cardiac myocytes and may function as a negative modulator of I(Ks) current amplitude in the heart., Wu DM., Heart Rhythm. December 1, 2006; 3 (12): 1469-80.
	Skipping of Exon 1 in the KCNQ1 gene causes Jervell and Lange-Nielsen syndrome., Zehelein J., J Biol Chem. November 17, 2006; 281 (46): 35397-403.
	Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel., Bett GC., J Physiol. November 1, 2006; 576 (Pt 3): 755-67.
	Frequency-dependent modulation of KCNQ1 and HERG1 potassium channels., Diness TG., Biochem Biophys Res Commun. May 19, 2006; 343 (4): 1224-33.
	De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero., Hong K., Cardiovasc Res. December 1, 2005; 68 (3): 433-40.
	The MinK-related peptides., McCrossan ZA., Neuropharmacology. November 1, 2004; 47 (6): 787-821.
	Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects., Schram G., Br J Pharmacol. August 1, 2004; 142 (8): 1300-8.
	Association of the serum and glucocorticoid regulated kinase (sgk1) gene with QT interval., Busjahn A., Cell Physiol Biochem. January 1, 2004; 14 (3): 135-42.
	Human beta(3)-adrenoreceptors couple to KvLQT1/MinK potassium channels in Xenopus oocytes via protein kinase C phosphorylation of the KvLQT1 protein., Kathöfer S., Naunyn Schmiedebergs Arch Pharmacol. August 1, 2003; 368 (2): 119-26.
	KCNQ1 channels sense small changes in cell volume., Grunnet M., J Physiol. June 1, 2003; 549 (Pt 2): 419-27.
	Novel gene hKCNE4 slows the activation of the KCNQ1 channel., Teng S., Biochem Biophys Res Commun. April 11, 2003; 303 (3): 808-13.
	Regulation of KCNE1-dependent K(+) current by the serum and glucocorticoid-inducible kinase (SGK) isoforms., Embark HM., Pflugers Arch. February 1, 2003; 445 (5): 601-6.
	Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action., Kushida S., Eur J Pharmacol. December 13, 2002; 457 (1): 19-27.
	Inhibition of cardiac potassium currents by pentobarbital., Bachmann A., Naunyn Schmiedebergs Arch Pharmacol. January 1, 2002; 365 (1): 29-37.
	Chromanol 293B, a blocker of the slow delayed rectifier K+ current (IKs), inhibits the CFTR Cl- current., Bachmann A., Naunyn Schmiedebergs Arch Pharmacol. June 1, 2001; 363 (6): 590-6.
	minK-related peptide 1 associates with Kv4.2 and modulates its gating function: potential role as beta subunit of cardiac transient outward channel?, Zhang M., Circ Res. May 25, 2001; 88 (10): 1012-9.
	Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel., Mergenthaler J., Naunyn Schmiedebergs Arch Pharmacol. April 1, 2001; 363 (4): 472-80.
	Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current., Kamiya K., Circulation. March 6, 2001; 103 (9): 1317-24.
	MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis., Abbott GW., Cell. January 26, 2001; 104 (2): 217-31.
	Inhibition of IKs channels by HMR 1556., Gögelein H., Naunyn Schmiedebergs Arch Pharmacol. December 1, 2000; 362 (6): 480-8.
	Functional coupling of human beta 3-adrenoreceptors to the KvLQT1/MinK potassium channel., Kathöfer S., J Biol Chem. September 1, 2000; 275 (35): 26743-7.
	Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents., Ulens C., Cardiovasc Res. December 1, 1999; 44 (3): 568-78.
	Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome., Sesti F., J Gen Physiol. December 1, 1998; 112 (6): 651-63.
	Independent and exclusive modulation of cardiac delayed rectifying K+ current by protein kinase C and protein kinase A., Lo CF., Circ Res. November 16, 1998; 83 (10): 995-1002.
	Activation and inactivation of homomeric KvLQT1 potassium channels., Pusch M., Biophys J. August 1, 1998; 75 (2): 785-92.
	A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents., Salata JJ., Mol Pharmacol. July 1, 1998; 54 (1): 220-30.
	Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes., Bosch RF., Cardiovasc Res. May 1, 1998; 38 (2): 441-50.
	Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action., Busch AE., Br J Pharmacol. January 1, 1998; 123 (1): 23-30.
	Suppression of slow delayed rectifier current by a truncated isoform of KvLQT1 cloned from normal human heart., Jiang M., J Biol Chem. September 26, 1997; 272 (39): 24109-12.
	KVLQT channels are inhibited by the K+ channel blocker 293B., Bleich M., Pflugers Arch. August 1, 1997; 434 (4): 499-501.

???pagination.result.page??? 1 2 ???pagination.result.next???